| Announce Date | 10/30/2025 |
| EPS Normalized Actual | $0.4629 (Miss by $-0.2571) |
| EPS GAAP Actual | $0.4629 (Miss by $-0.2571) |
| Revenue Actual | $0.8071B |
| Revenue Surprise | Beat by $807.1M |
| Announce Date | 12/31/1969 (Pre-Market) |
| EPS Normalized Estimate | $ |
| EPS GAAP Estimate | $ |
| Revenue Estimate | $0B |
| Fiscal Period Ending | EPS Estimate | Forward PE | Low | High | # of Analysts |
|---|---|---|---|---|---|
| Dec 2029 | 5.68 | 21.54 | 5.50944 | 5.9478 | 1 |
| Dec 2028 | 4.77 | 25.66 | 4.62676 | 4.99489 | 1 |
| Period | EPS | Beat / Miss | Revenue | YoY | Beat / Miss |
|---|---|---|---|---|---|
| FQ3 2025 (Sep 2025) | 0.46 | 0.46 | 0.8071B | -0.07% | 807.1M |
| FQ2 2025 (Jun 2025) | 0.34 | 0.34 | 0.7924B | -2.56% | 792.4M |
| FQ1 2025 (Mar 2025) | 0.42 | 0.42 | 0.7732B | 0.28% | 773.2M |
| FQ4 2024 (Dec 2024) | 0.68 | 0.68 | 0.849837B | 4.42% | 849.84M |
| FQ3 2024 (Sep 2024) | 0.51 | 0.51 | 0.807694B | -11.55% | 807.69M |
| FQ2 2024 (Jun 2024) | 0.45 | 0.45 | 0.812652B | -13.5% | 812.65M |
| FQ1 2024 (Mar 2024) | 0.3 | 0.3 | 0.771025B | 100% | 771.03M |
| FQ4 2023 (Dec 2023) | 0.25 | 0.25 | 0.812291B | 100% | 812.29M |
FQ4 Announce Date
12/31/1969 (Pre-Market)
Consensus EPS Estimates
Consensus Revenue Estimates
0B
| Fiscal Period Ending | EPS Estimate | YoY Growth(%) | Low | High | # of Analysts |
|---|---|---|---|---|---|
| FQ4 2028 (Dec 2028) | 1.164 | -- | 1.1083 | 1.21513 | 3 |
| FQ3 2028 (Sep 2028) | 1.1517 | -- | 1.09659 | 1.20229 | 3 |
| FQ2 2028 (Jun 2028) | 1.07 | -- | 1.0188 | 1.117 | 3 |
| FQ1 2028 (Mar 2028) | 0.986 | -- | 0.93882 | 1.02931 | 3 |
| FQ4 2027 (Dec 2027) | 1.13948 | -- | 1.11297 | 1.16574 | 4 |
| FQ3 2027 (Sep 2027) | 1.09285 | -- | 1.06742 | 1.11803 | 4 |
| FQ2 2027 (Jun 2027) | 0.988 | -- | 0.96501 | 1.01076 | 4 |
| FQ1 2027 (Mar 2027) | 1.13401 | -- | 1.12163 | 1.15661 | 2 |
| Fiscal Period Ending | Revenue Estimate | YoY Growth(%) | Low | High | # of Analysts |
|---|---|---|---|---|---|
| FQ4 2028 (Dec 2028) | 1B | -- | 0.96B | 1.03B | 2 |
| FQ3 2028 (Sep 2028) | 0.99B | -- | 0.96B | 1.03B | 2 |
| FQ2 2028 (Jun 2028) | 0.96B | -- | 0.93B | 0.99B | 2 |
| FQ1 2028 (Mar 2028) | 0.9B | -- | 0.86B | 0.93B | 2 |
| FQ4 2027 (Dec 2027) | 0.96B | -- | 0.95B | 0.98B | 2 |
| FQ3 2027 (Sep 2027) | 0.95B | -- | 0.93B | 0.97B | 2 |
| FQ2 2027 (Jun 2027) | 0.91B | -- | 0.9B | 0.93B | 2 |
| FQ1 2027 (Mar 2027) | 0.96B | -- | 0.96B | 0.98B | 2 |
EPS # of Up Revisions
4
EPS # of Down Revisions
4
Revenue # of Up Revisions
6
Revenue # of Down Revisions
3
| Fiscal Period Ending | EPS Estimate | YoY Growth | Low | High | # of Analysts |
|---|---|---|---|---|---|
| FQ4 2021 (Dec 2021) | 0.41 | -12.52% | 0.39 | 0.48 | 20 |
| FQ1 2022 (Mar 2022) | 0.59 | 6.89% | 0.55 | 0.62 | 15 |
| FQ2 2022 (Jun 2022) | 0.70 | 2.62% | 0.61 | 0.74 | 15 |
| FQ3 2022 (Sep 2022) | 0.68 | 4.62% | 0.65 | 0.70 | 15 |
| Fiscal Period Ending | EPS Estimate | YoY Growth | Low | High | # of Analysts |
|---|---|---|---|---|---|
| FQ4 2021 (Dec 2021) | 0.41 | -12.52% | 0.39 | 0.48 | 20 |
| FQ1 2022 (Mar 2022) | 0.59 | 6.89% | 0.55 | 0.62 | 15 |
| FQ2 2022 (Jun 2022) | 0.70 | 2.62% | 0.61 | 0.74 | 15 |
| FQ3 2022 (Sep 2022) | 0.68 | 4.62% | 0.65 | 0.70 | 15 |
EPS # of Beats
8
EPS # of Misses
0
EPS # of in-lines
0
Revenue # of Beats
8
Revenue # of Misses
0
Revenue # of in-lines
0
| Earnings Date | EPS Estimate | EPS Actual | Surprise | Surprise % |
|---|---|---|---|---|
| FQ3 2025 (Sep 2025) | 0.46 | 0.46 | 100% | |
| FQ2 2025 (Jun 2025) | 0.34 | 0.34 | 100% | |
| FQ1 2025 (Mar 2025) | 0.42 | 0.42 | 100% | |
| FQ4 2024 (Dec 2024) | 0.68 | 0.68 | 100% | |
| FQ3 2024 (Sep 2024) | 0.51 | 0.51 | 100% | |
| FQ2 2024 (Jun 2024) | 0.45 | 0.45 | 100% | |
| FQ1 2024 (Mar 2024) | 0.3 | 0.3 | 100% | |
| FQ4 2023 (Dec 2023) | 0.25 | 0.25 | 100% |
| Earnings Date | Revenue Estimate | Revenue Actual | Surprise | Surprise % |
|---|---|---|---|---|
| FQ3 2025 (Sep 2025) | $0B | $0.81B | $807.1M | 100% |
| FQ2 2025 (Jun 2025) | $0B | $0.79B | $792.4M | 100% |
| FQ1 2025 (Mar 2025) | $0B | $0.77B | $773.2M | 100% |
| FQ4 2024 (Dec 2024) | $0B | $0.85B | $849.84M | 100% |
| FQ3 2024 (Sep 2024) | $0B | $0.81B | $807.69M | 100% |
| FQ2 2024 (Jun 2024) | $0B | $0.81B | $812.65M | 100% |
| FQ1 2024 (Mar 2024) | $0B | $0.77B | $771.03M | 100% |
| FQ4 2023 (Dec 2023) | $0B | $0.81B | $812.29M | 100% |